SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation

Michael J. Arnold, Andrew Buelt

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)675-677
Number of pages3
JournalAmerican Family Physician
Volume105
Issue number6
StatePublished - 1 Jun 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation'. Together they form a unique fingerprint.

Cite this